Combined heart-liver transplantation in the MELD era: Do waitlisted patients require exception status?

American Journal of Transplantation

Volumn 14, Issue 3, 2014, Pages 647-659

  Schaffer, J M ^a   Chiu, P ^a   Singh, S K ^b,c   Oyer, P E ^a   Reitz, B A ^a   Mallidi, H R ^b,c  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c TEXAS HEART INSTITUTE   (United States)

Author keywords

heart transplantation; Heart liver transplantation; outcomes; survival

Indexed keywords

ADULT; ARTICLE; DISEASE SEVERITY; FEMALE; HEART LIVER TRANSPLANTATION; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; ISOLATED HEART; ISOLATED HEART TRANSPLANT; ISOLATED LIVER; ISOLATED LIVER TRANSPLANT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MODEL FOR END STAGE LIVER DISEASE SCORE; PRIORITY JOURNAL;

HEART TRANSPLANTATION; HEART-LIVER TRANSPLANTATION; OUTCOMES; SURVIVAL;

END STAGE LIVER DISEASE; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TISSUE AND ORGAN PROCUREMENT; WAITING LISTS;

EID: 84896727859     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12595     Document Type: Article

References (26)

1. Starzl TE, Bilheimer DW, Bahnson HT, et al. Heart-liver transplantation in a patient with familial hypercholesterolaemia. Lancet 1984; 1: 1382-1383.
2. Nardo B, Beltempo P, Bertelli R, et al. Combined heart and liver transplantation in four adults with familial amyloidosis: Experience of a single center. Transplant Proc 2004; 36: 645-647.
3. Porrett PM, Desai SS, Timmins KJ, Twomey CR, Sonnad SS, Olthoff KM., Combined orthotopic heart and liver transplantation: The need for exception status listing. Liver Transpl 2004; 10: 1539-1544.
4. Raichlin E, Daly RC, Rosen CB, et al. Combined heart and liver transplantation: A single-center experience. Transplantation 2009; 88: 219-225.
5. Barreiros AP, Post F, Hoppe-Lotichius M, et al. Liver transplantation and combined liver-heart transplantation in patients with familial amyloid polyneuropathy: A single-center experience. Liver Transpl 2010; 16: 314-323.
6. Nagpal AD, Chamogeorgakis T, Shafii AE, et al. Combined heart and liver transplantation: The Cleveland Clinic experience. Ann Thorac Surg 2013; 95: 179-182.
7. Te HS, Anderson AS, Millis JM, Jeevanandam V, Jensen DM., Current state of combined heart-liver transplantation in the United States. J Heart Lung Transplant 2008; 27: 753-759.
8. Cannon RM, Hughes MG, Jones CM, Eng M, Marvin MR., A review of the United States experience with combined heart-liver transplantation. Transpl Int 2012; 25: 1223-1228.
9. UNOS Policy. 3.7 Organ distribution: Allocation of thoracic organs. Available at: http://optn.transplant.hrsa.gov/PoliciesandBylaws2/policies/pdfs/ policy-9.pdf. Accessed March 1, 2013.
10. UNOS Policy. 3.6 Organ distribution: Allocation of livers. Available at: http://optn.transplant.hrsa.gov/PoliciesandBylaws2/policies/pdfs/policy-8.pdf. Accessed March 1, 2013.
11. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470.
12. Singh TP, Almond CS, Taylor DO, Graham DA., Decline in heart transplant wait list mortality in the United States following broader regional sharing of donor hearts. Circ Heart Fail 2012; 5: 249-258.
13. Kim WR, Therneau TM, Benson JT, et al. Deaths on the liver transplant waiting list: An analysis of competing risks. Hepatology 2006; 43: 345-351.
14. Rubin DB, Schenker N., Multiple imputation in health-care databases: An overview and some applications. Stat Med 1991; 10: 585-598.
15. Gelman A, Rubin DB., Markov chain Monte Carlo methods in biostatistics. Stat Methods Med Res 1996; 5: 339-355.
16. Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: Potential and pitfalls. BMJ 2009; 338: b2393.
17. Rubin DB., Multiple imputation after 18+ years (with discussion). J Am Stat Assoc 1996; 91: 473-489.
18. Prentice RL, Kalbfleisch JD, Peterson AV Jr, Flournoy N, Farewell VT, Breslow NE., The analysis of failure times in the presence of competing risks. Biometrics 1978; 34: 541-554.
19. Pepe MS, Mori M., Kaplan-Meier marginal or conditional probability curves in summarizing competing risks failure time data ? Stat Med 1993; 12: 737-751.
20. Kaplan E, Meier P., Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
21. Bland JM, Altman DG., The log rank test. BMJ 2004; 328: 1073.
22. Cox DR., Regression models and life-tables. Ser B Stat Methodol 1972; 34: 187-220.
23. Rothman KJ., No adjustments are needed for multiple comparisons. Epidemiology 1990; 1: 43-46.
24. Weiss ES, Allen JG, Arnaoutakis GJ, et al. Creation of a quantitative recipient risk index for mortality prediction after cardiac transplantation (IMPACT). Ann Thorac Surg 2011; 92: 914-921, discussion 921-922.
25. Cheng CH, Lee CF, Soong RS, et al. Risk factors and clinical outcomes of ventilator-associated pneumonia in patients on the liver transplant waiting list. Transplant Proc 2012; 44: 762-764.
26. Thabut G, Fournier M., Assessing survival benefits from lung transplantation. Rev Mal Respir 2011; 28: e1-e6.